Role of serotonin in the immune system and in neuroimmune interactions

Brain, Behavior, and Immunity

Volumn 12, Issue 4, 1998, Pages 249-271

  Mössner, Rainald ^a   Lesch, Klaus Peter ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTACTIC FACTOR; NEUROTRANSMITTER; SEROTONIN; SEROTONIN RECEPTOR;

ANIMAL CELL; ARTICLE; CENTRAL NERVOUS SYSTEM; DELAYED HYPERSENSITIVITY; EXTRACELLULAR SPACE; GENE DISRUPTION; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INFLAMMATION; ISCHEMIA; MACROPHAGE; MOLECULAR BIOLOGY; MOUSE; NATURAL KILLER CELL; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; THROMBOSIS;

EID: 0344004854     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1006/brbi.1998.0532     Document Type: Article

References (143)

1. Ader R., Felten D., Cohen N. Interactions between the brain and the immune system. Annu. Rev. Pharmacol. Toxicol. 30:1990;561-602.
2. Ader R., Cohen N., Felten D. Psychoneuroimmunology: Interactions between the nervous system and the immune system. Lancet. 345:1995;99-103.
3. Al'perina E. L., Idova G. V., Devoino L. V. Role of the pituitary in modulating the effect of the dopaminergic and serotoninergic systems on the immune response. Fiziol. Zh. SSSR. 71:1985;1428-1432.
4. Ameisen J. C., Meade R., Askenase P. W. A new interpretation of the involvement of serotonin in delayed-type hypersensitivity. J. Immunol. 142:1989;3171-3179.
5. Arzt E., Costas M., Finkielman S., Nahmod V. E. Serotonin inhibition of tumour necrosis factor alpha synthesis by human monocytes. Life Sci. 48:1991;2557-2562.
6. Arzt E. S., Fernandez-Castelo S., Finocchiaro L. M. E., Criscuolo M. E., Diaz A., Finkielman S., Nahmod V. E. Immunomodulation by indoleamines: Serotonin and melatonin action on DNA and interferon-gamma synthesis by human peripheral blood mononuclear cells. J. Clin. Immunol. 8:1988;513-520.
7. Askenase P. W., Herzog W. R., Millet I., Paliwal V., Ramabhadran R., Rochester C., Geba G. P., Ptak W. Serotonin initiation of delayed-type hypersensitivity: Mediation by a primitive Thy-1 antigen-specific clone or by specific monoclonal IgE antibody. Skin Pharmacol. 4:1991;25-42.
8. Aune T. M., Golden H. W., McGrath K. M. Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte functionin vitro. J. Immunol. 153:1994;489-498.
9. Aune T. M., Kelley K. A., Ranges G. E., Bombara M. P. Serotonin-activated signal transduction via serotonin receptors on Jurkat cells. J. Immunol. 145:1990;1826-1831.
10. Aune T. M., McGrath K. M., Sarr T., Bombara, Kelley K. A. Expression of 5HT1a receptors on activated human T cells. J. Immunol. 151:1993;1175-1183.
11. Baker A. J., Zornow M. H., Scheller M. S., Yaksh T. L., Skilling S. R., Smullin D. H., Larson A. A., Kuczenski R. Changes in extracellular concentrations of glutamate, aspartate, glycine, dopamine, serotonin, and dopamine metabolites after transient global ischemia in the rabbit brain. J. Neurochem. 57:1991;1370-1379.
12. Bebo B. F., Yong T., Orr E. L., Linthicum D. S. Hypothesis: A possible role for mast cells and their inflammatory mediators in the pathogenesis of autoimmune encephalomyelitis. J. Neurosci. Res. 45:1996;340-348.
13. Bengel D., Murphy D. L., Andrews A. M., Wichems C. H., Feltner D., Heils A., Mössner R., Westphal H., Lesch K. P. Reduced brain serotonin and locomotor insensitivity to MDMA ("ecstasy") in serotonin transporter-deficient mice. Mol. Pharmacol. 53:1998;649-655.
14. Bengtsson B. O., Zhu J., Thorell L. H., Olsson T., Link H. Effects of zimeldine and its metabolites, clomipramine, imipramine and maprotiline in experimental allergic neuritis. J. Neuroimmunol. 39:1992;109-122.
15. Bernton E. W., Bryant H. U., Holaday J. W. Prolactin and immune function. Psychoneuroimmunology. 1991;Academic Press, New York. p. 403-428.
16. Besedovsky H. O., del Rey A. Immune-neuro-endocrine interactions: Facts and hypotheses. Endocr. Rev. 17:1996;64-102.
17. Bianchi M., Clavenna A., Bondiolotti G. P., Ferrario P., Panerai A. E. GM-CSF affects hypothalamic neurotransmitter levels in mice: Involvement of interleukin-1. Neuroreport. 8:1997;3587-3590.
18. Boess F. G., Martin I. L. Molecular biology of 5-HT receptors. Neuropharmacol. 33:1994;275-317.
19. Bonnet M., Lespinats G., Burtin C. Histamine and serotonin suppression of lymphocyte response to phytohemagglutinin and allogeneic cells. Cell. Immunol. 83:1984;280-291.
20. Carlson S. L., Felten D. L., Livnat S., Felten S. Y. Alterations of monoamines in specific central autonomic nuclei following immunization in mice. Brain, Behav. Immun. 1:1987;52-63.
21. Chang J. Y., Ekblad E., Kannisto P., Owman C. Serotonin uptake into cerebrovascular nerve fibers of the rat, visualization by immunohistochemistry, disappearance following sympathectomy, and release during electrical stimulation. Brain Res. 492:1989;79-88.
22. Choquet D., Korn H. Dual effects of serotonin on a voltage-gated conductance in lymphocytes. Proc. Natl. Acad. Sci. USA. 85:1988;4557-4561.
23. Clancy J., Petrovic L. M., Gordon B. H., Handa R. J., Campbell D. B., Lorens S. A. Effects of subchronicD. J. Immunopharmacol. 13:1991;1203-1212.
24. Cohen R. A., Zitnay K. M., Weisbrod R. M. Platelet-induced neurogenic coronary contractions due to accumulation of the false neurotransmitter, 5-hydroxytryptamine. J. Clin. Invest. 75:1985;286-292.
25. Cohen R. A., Zitnay K. M., Weisbrod R. M. Accumulation of 5-hydroxytryptamine leads to dysfunction of adrenergic nerves in canine coronary artery following intimal damagein vivo. Circ. Res. 61:1987;829-833.
26. Collier D. A., Stöber G., Li T., Heils A., Catalano M., Di Bella D., Arranz M. J., Murray R. M., Vallada H. P., Bengel D., Müller C. R., Roberts G. W., Smeraldi E., Kirov G., Sham P., Lesch K. P. Susceptibility to bipolar affective disorder and unipolar depression is influenced by allelic variation of functional serotonin transporter expression. Mol. Psychiatry. 1:1996;453-460.
27. Crivellato E., Damiani D., Mallardi F., Travan L. Suggestive evidence for a microanatomical relationship between mast cells and nerve fibers containing substance P, calcitonin gene related peptide, vasoactive intestinal polypeptide, and somatostatin in the rat mesentery. Acta Anat. 141:1991;127-131.
28. Cross R. J., Brooks W. H., Roszman T. L., Markesbery W. R. Hypothalamic-immune interactions. Effect of hypophysectomy on neuroimmunomodulation. J. Neurol. Sci. 53:1982;557-566.
29. Damsma G., Boisvert D. P., Mudrick L. A., Wenkstern D., Fibiger H. C. Effects of transient forebrain ischemia and pargyline on extracellular concentrations of dopamine, serotonin, and their metabolites in the rat striatum as determined byin vivo. J. Neurochem. 54:1990;801-808.
30. Das A. M., Flower R. J., Perretti M. Eotaxin-induced eosinophil migration in the peritoneal cavity of ovalbumin-sensitized mice. J. Immunol. 159:1997;1466-1473.
31. Decombe R., Bentue-Ferrer D., Allain H., Driessche J. V. D. Alteration of aminergic neurotransmitter release after two consecutive transient global ischemias: An in vivo microdialysis study in rat. Neurol. Res. 15:1993;192-197.
32. Devoino L., Eliseeva L., Eremina O., Idova G., Cheido M. 5-hydroxytryptophan effect on the development of the immune response: IgM and IgG antibodies and rosette formation in primary and secondary responses. Eur. J. Immunol. 5:1975;394-399.
33. Dietsch G. N., Hinrichs D. J. The role of mast cells in the elicitation of experimental allergic encephalomyelitis. J. Immunol. 142:1989;1476-1481.
34. Dimitriadou V., Buzzi M. G., Theoharides T. C., Moskowitz M. A. Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation. Neuroscience. 44:1991;97-112.
35. Dropp J. Mast cells in mammalian brain. I. Distribution. Acta Anat. 94:1976;1-21.
36. Dunn A. J., Powell M. L., Moreshead W. V., Gaskin J. M., Hall N. R. Effects of Newcastle disease virus administration to mice on the metabolism of cerebral biogenic amines, plasma corticosterone, and lymphocyte proliferation. Brain Behav. Immun. 1:1987;216-230.
37. Dunn A. J. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism paralleling the increased plasma corticosterone. Life Sci. 43:1988;429-435.
38. Dunn A. J., Powell M. L., Meitin C., Small P. A. Virus infection as a stressor: Influenza virus elevates plasma concentrations of corticosterone, and brain concentrations of MHPG and tryptophan. Physiol. Behav. 45:1989;591-594.
39. Dunn A. J., Welch J. Stress- and endotoxin-induced increases in brain tryptophan and serotonin metabolism depend on sympathetic nervous system activity. J. Neurochem. 57:1991;1615-1622.
40. Edens F. W., McCorkle F. M., Simmons D. G., Yersin A. G. Effects of Bordetella avium on lymphoid tissue monoamine concentrations in turkey poults. Avian Dis. 31:1987;746-751.
41. Edvinsson L., Cervos-Navarro J., Larsson L., Owman C., Ronnberg A. Regional distribution of mast cells containing histamine, dopamine, or 5-hydroxytryptamine in the mammalian brain. Neurology. 27:1977;878-883.
42. Elisieva L. S., Stefanovich L. E. Specific binding of serotonin by blood leukocytes and peritoneal cells in the mouse. Biokhimica. 47:1982;810-815.
43. Endo Y., Nakamura M. The effect of lipopolysaccharide, interleukin-1, and tumor necrosis factor on the hepatic accumulation of 5-hydroxytryptamine and platelets in the mouse. Br. J. Pharmacol. 105:1992;613-619.
44. Endo Y., Nakamura M. Active translocation of platelets into sinusoidal and Disse spaces in the liver in response to lipopolysaccharide, interleukin-1, and tumor necrosis factor. Gen. Pharmacol. 24:1993;1039-1053.
45. Endo Y., Shibazaki M., Nakamura M., Takada H. Contrasting effects of lipopolysaccharides (endotoxins) from oral black-pigmented bacteria and enterobacteriaceae on platelets, a major source of serotonin, and on histamine-forming enzyme in mice. J. Infect. Dis. 175:1997;1404-1412.
46. Erspamer V. Pharmacology of enteramine. I. Action of acetone extract of rabbit stomach mucosa on blood pressure and on surviving isolated organs. Naun. Schmied. Arch. Exp. Path. Pharmakol. 196:1940;343-365.
47. Erspamer V., Asero B. Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine. Nature. 169:1952;800-801.
48. Essmann W. B. Serotonin in health and disease. 1978a;Spectrum, New York.
49. Essmann W. B. Serotonin distribution in tissue and fluids. Essmann W. B. Serotonin in health and disease. 1978b;Spectrum, New York.
50. Farber H. W., Beer D. J. Restricted secretion of a T-lymphocyte chemotactic cytokine by serotonin-stimulated cultured aortic endothelial cells. Circ. Res. 69:1991;257-265.
51. Fassbender K., Mössner R., Motsch L., Kischka U., Grau A., Hennerici M. Circulating selectin- and immunoglobulin-type adhesion molecules in acute ischemic stroke. Stroke. 26:1995;1361-1364.
52. Felten S. Y., Olschowka J. A. Noradrenergic sympathetic innervation of the spleen: II. Tyrosine hydroxylase (TH)-positive nerve terminals form synaptic-like contacts on lymphocytes in the splenic white pulp. J. Neurosci. Res. 18:1987;37-48.
53. Finocchiaro L. M. E., Arzt E. S., Fernandez-Castelo S., Criscuolo M., Finkielman S., Nahmod V. E. Serotonin and melatonin synthesis in peripheral blood mononuclear cells: Stimulation by interferon-gamma as part of an immunomodulatory pathway. J. Interferon Res. 8:1988;705-715.
54. Foon K. A., Wahl S. M., Oppenheim J. J., Rosenstreich D. L. Serotonin-induced production of a monocyte chemotactic factor by human peripheral blood leukocytes. J. Immunol. 117:1976;1545-1552.
55. Fuchs B. A., Campbell K. S., Munson A. E. Norepinephrine and serotonin content of the murine spleen: Its relationship to lymphocyte beta-adrenergic receptor density and the humoral immune responsein vivoin vitro. Cell. Immunol. 117:1988;339-351.
56. Fukui H., Yamamoto M., Ando T., Sasaki S., Sato S. Increase in serotonin levels in the dog ileum and blood by cisplatin as measured by micodialysis. Neuropharmacology. 32:1993;959-968.
57. Gardier A. M., Kachaner S., Shaghaghi E. K., Blot C., Bohuon C., Jacquot C., Pallardy M. J. Effects of a primary immune response to T-cell dependent antigen on serotonin metabolism in frontal cortex:In vivo. Brain Res. 645:1994;150-156.
58. Geba G. P., Ptak W., Anderson G. M., Paliwal V., Ratzlaff R. E., Levin J., Askenase P. W. Delayed-type hypersensitivity in mast cell-deficient mice. J. Immunol. 157:1996;557-565.
59. Germonpre P. R., Joos G. F., Pauwels R. A. Characterization of the neurogenic plasma extravasation in the airways. Arch. Int. Pharmacodyn. 329:1995;185-203.
60. Goppelt-Struebe M., Stroebel M. Synergistic induction of monocyte chemoattractant protein-1 (MCP-1) by platelet-derived growth factor and interleukin-1. FEBS Lett. 374:1995;375-378.
61. Gray R. S., McCorkle F. M., Denno K. M., Taylor R. L. Modulation of chicken plaque-forming cells by serotonin and dopamine. Poultry Sci. 70:1991;1521-1526.
62. Gripenberg J. Inhibition by reserpine, guanethidine and imipramine of the uptake of 5-hydroxytryptamine by rat peritoneal mast cells. Acta Physiol. Scand. 96:1976;407-416.
63. Heidmann D. E. A., Metcalf M. A., Kohen R., Hamblin M. W. Four 5-hydroxytryptamine7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: Species differences due to altered intron-exon organization. J. Neurochem. 68:1997;1372-1381.
64. Hellstrand K., Czerkinsky C., Ricksten A., Jansson B., Asea A., Kylefjord H., Hermodsson S. Role of serotonin in the regulation of interferon-gamma production by human natural killer cells. J. Interferon Res. 13:1993;33-38.
65. Hellstrand K., Hermodsson S. Serotonergic 5-HT1A receptors regulate a cell contact-mediated interaction between natural killer cells and monocytes. Scand. J. Immunol. 37:1993;7-18.
66. Hellstrand K., Hermodsson S. Enhancement of human natural killer cell cytotoxicity by serotonin: Role of non-T/CD16+ NK cells, accessory monocytes, and 5-HT1A receptors. Cell. Immunol. 127:1990a;199-214.
67. Hellstrand K., Hermodsson S. Monocyte-mediated suppression of IL-2-induced NK-cell activation. Scand. J. Immunol. 32:1990b;183-192.
68. Hofmann B., Nishanian P., Nguyen T., Liu M., Fahey J. L. Restoration of T cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues. AIDS. 7:1993;659-664.
69. Hofmann B., Afzelius P., Iverson J., Kronborg G., Aabech P., Benfield T., Dybkjaer E., Nielsen J. O. Buspirone, a serotonin receptor agonist, increases CD4 T-cell counts and modulates the immune system in HIV-seropositive subjects. AIDS. 10:1996;1339-1347.
70. Holzwarth M. A., Brownfield M. S. Serotonin coexists with epinephrine in rat adrenal medullary cells. Neuroendocrinology. 41:1985;230-236.
71. Ibrahim M. The mast cells of the mammalian central nervous system. I. Morphology, distribution and histochemistry. J. Neurol. Sci. 21:1974;431-478.
72. Iken K., Chheng S., Fargin A., Goulet A. C., Kouassi E. Serotonin upregulates mitogen-stimulated B lymphocyte proliferation through 5-HT1A receptors. Cell.Immunol. 163:1995;1-9.
73. Jackson J. C., Cross R. J., Walker R. F., Markesbery W. R., Brooks W. H., Roszman T. L. I. Influence of serotonin on the immune response. Immunology. 54:1985;505-512.
74. Jackson J. C., Walker R. F., Brooks W. H., Roszman T. L. Specific uptake of serotonin by murine macrophages. Life Sci. 42:1988;1641-1650.
75. Jasper J. R., Kosaka A., To Z. P., Chang D. J., Eglen R. M. Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7(b)). Br. J. Pharmacol. 122:1997;126-132.
76. Junod A. F. Uptake, metabolism, and efflux of C14-5-hydroxtryptamine in isolated perfused rat lungs. J. Pharmacol. Exp. Ther. 183:1972;341-355.
77. Kabiersch A., del Rey A., Honegger C. G., Besedovsky H. O. Interleukin-1 induces changes in norepinephrine metabolism in the rat brain. Brain Behav. Immun. 2:1988;267-274.
78. Kelley K. W. Growth hormone in immunobiology. Ader R., Cohen N., Felten D. L. Psychoneuroimmunology. 1991;377-402 Academic, New York.
79. Keith I. M., Jin J., Saban R. Nerve-mast cell interaction in normal guinea pig urinary bladder. J. Comp. Neurol. 363:1995;28-36.
80. Khan I. A., Bhardwaj G., Malla N., Wattal C., Agarwal S. C. Effect of serotonin on T lymphocyte proliferationin vitro. Int. Arch. Allergy Appl. Immunol. 81:1986;378-380.
81. Kondoh T., Korosue K., Lee S. H., Heros R. C., Low W. C. Evaluation of monoaminergic neurotransmitters in the rat striatum during varied global cerebral ischemia. Neurosurgery. 35:1994;278-286.
82. Kut J. L., Young M. R. I., Crayton J. W., Wright M. A., Young M. E. Regulation of murine T-lymphocyte function by spleen cell-derived and exogenous serotonin. Immunopharmacol. Immunotoxicol. 14:1992;783-796.
83. Laberge S., Cruikshank W. W., Beer D. J., Center D. M. Secretion of IL-16 (Lymphocyte Chemoattractant Factor) from serotonin-stimulated CD8+ T cellsin vitro. J. Immunol. 156:1996;310-315.
84. LeFever A., Liepins A., Truitt R. Role of K+ ion channels in lymphokine-activated killer (LAK) cell lytic function. Immunopharmacol. Immunotoxicol. 11:1989;571-582.
85. Lesch K. P., Bengel D., Heils A., Sabol S. Z., Greenberg B. D., Petri S., Benjamin J., Müller C. R., Hamer D. H., Murphy D. L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 274:1996;1483-1487.
86. Lesch K. P., Mössner R. Genetically driven variation in serotonin uptake: Is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? Biol. Psych. 44:1998;179-192.
87. Li F., Joshua I. G., Lian R., Justus D. E. Differing regulation of major histocompatibility class II and adhesion molecules on human umbilical vein endothelial cell by serotonin. Int. Arch. Allergy Appl. Immunol. 112:1997a;145-151.
88. Li T., Holmes C., Sham P. C., Birkett J., Kirov G., Lesch K. P., Powell J., Lovestone S., Collier D. Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's disease. Neuroreport. 8:1997b;683-686.
89. Liepins A., LeFever A., Truitt R. L. Serotonin modulated Ca++ dependent K+ channels in alloimmune effector cell lytic function. Immunopharmacol. Immunotoxicol. 11:1989;165-178.
90. Linthicum D. S. Development of acute autoimmune encephalomyelitis in mice: Factors regulating the effector phase of the disease. Immunobiology. 162:1982;211-220.
91. Linthorst A. C. E., Flachskamm C., Holsboer F., Reul J. M. H. M. Activation of serotonergic and noradrenergic neurotransmission in the rat hippocampus after peripheral administration of bacterial endotoxin: Involvment of the cyclo-oxygenase pathway. Neuroscience. 72:1996;989-997.
92. Linthorst A. C. E., Flachskamm C., Müller-Preuss P., Holsboer F., Reul J. M. H. M. Effect of bacterial endotoxin and interleukin-1beta on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: An in vivo microdialysis study. J. Neurosci. 15:1995;2920-2934.
93. Lukacs N. W., McCorkle F. M., Taylor R. L. Monoamines suppress the phytohemagglutinin wattle response in chickens. Dev. Comp. Immunol. 11:1987;759-768.
94. MacPhee I. A., Antoni F. A., Mason D. W. Spontaneous recovery of rats from EAE is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J. Exp. Med. 169:1989;431-445.
95. Marathias K., Lambracht-Hall M., Savala J., Theoharides T. C. Endogenous regulation of rat brain mast cell serotonin release. Int. Arch. Allergy Appl. Immunol. 95:1991;332-340.
96. Mathiau P., Reynier-Rebuffel A. M., Issertial O., Callebert J., Decreme C., Aubineau P. Absence of serotonergic innervation from raphe nuclei in rat cerebral blood vessels-II. Lack of tryptophan hydroxylase activityin vitro. Neuroscience. 52:1993a;657-665.
97. Mathiau P., Riche D., Behzadi G., Dimitriadou V., Aubineau P. Absence of serotonergic innervation from raphe nuclei in rat cerebral blood vessels - I. Histological evidence. Neuroscience. 52:1993b;645-655.
98. Matsuda H., Ushio H., Geba G. P., Askenase P. W. Human platelets can initiate T cell-dependent contact sensitivity through local serotonin release mediated by IgE antibodies. J. Immunol. 158:1997;2891-2897.
99. McCorkle F. M., Taylor R. L. Continous administration of 5-hydroxytryptamine alters cellular immunity in chickens. Comp. Biochem. Physiol. 94C:1989;511-514.
100. Meade R., Van Lovern H., Parmentier H., Iverson G. M., Askenase P. W. The antigen-binding T cell factor PC1-F sensitizes mast cells forin vitro. J. Immunol. 141:1988;2704-2713.
101. Merali Z., Lacosta S., Anisman H. Effects of interleukin-1beta and mild stress on alterations of norepinephrine, dopamine and serotonin neurotransmission: A regional microdialysis study. Brain Res. 761:1997;225-235.
102. Meyniel J. P., Khan N. A., Ferriere F., Deschaux P. Identification of lymphocyte 5-HT3 receptor subtype and its implication in fish T-cell proliferation. Immunol. Lett. 55:1997;151-160.
103. Mössner R., Heils A., Stöber G., Okladnova O., Daniel S., Lesch K. P. Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6. Neurochem. Int. 33:1998;251-254.
104. Nannmark U., Sennerby L., Bjursten L. M., Skolnik G., Bagge U. Inhibition of leukocyte phagocytosis by serotonin and its possible role in tumor cell destruction. Cancer Lett. 62:1992;83-86.
105. Paegelow I., Werner H., Hagen M., Wartner U., Lange P. Influence of serotonin on lymphokine secretion in vitro. Int. J. Immunopharmacol. 7:1985;889-896.
106. Paez K., Hernandez L. Simultaneous brain amd blood microdialysis study with a new removable venous probe. Serotonin and 5-hydroxyindolacetic acid changes after D-norfenfluramine or fluoxetine. Life Sci. 58:1996;1209-1221.
107. Page I. H. Foreword. Essmann W. B. Serotonin in health and disease. 1978;Spectrum, New York.
108. Paiva M. Q., Caramona M., Osswald W. Intra- and extraneuronal metabolism of 5-hydroxytryptamine in isolated saphenous vein of the dog. Naun. Schmied. Arch. Pharmacol. 325:1984;62-68.
109. Parrat J. R., West G. B. 5-Hydroxytryptamine and tissue mast cells. J. Physiol. 137:1957;169-178.
110. Parrat J. R. Discussion. Lewis G. P. 5-Hydroxytryptamine. 1958;36 Pergamon Press, London.
111. Phebus L. A., Clemens J. A. Effects of transient global cerebral ischemia on striatal extracellular dopamine, serotonin and their metabolites. Life Sci. 44:1989;1335-1342.
112. Polanski M., Karnovsky M. L. Serotonergic aspects of the response of human platelets to immune-adjuvant muramyl dipeptide. J. Neuroimmunol. 37:1992;149-160.
113. Polanski M., Vermeulen M. W., Wu J., Karnovsky M. L. Muramyl dipeptide mimicry in the regulation of murine macrophage activation by serotonin. Int. J. Immunopharmacol. 17:1995;225-232.
114. Qiu Y., Peng Y., Wang J. Immunoregulatory role of neurotransmitters. Adv. Neuroimmunol. 6:1996;223-231.
115. Ramamoorthy S., Ramamoorthy J. D., Prasad P. D., Bhat G. K., Mahesh V. B., Leibach F. H., Ganapathy V. Regulation of the human serotonin transporter by interleukin-1beta. Biochem. Biophys. Res. Comm. 216:1995;560-567.
116. Rapport M. M., Green A. A., Page I. H. Serum vasoconstrictor (serotonin). IV. Isolation and characterization. J. Biol. Chem. 176:1948;1243-1251.
117. Rapport M. Serum vasoconstrictor (serotonin). V. The presence of creatinine in the complex. A proposed structure of the vasoconstrictor principle. J. Biol. Chem. 180:1949;961-969.
118. Richards D. A., Obrenovitch T. P., Symon L., Curzon G. Extracellular dopamine and serotonin in the rat striatum during transient ischaemia of different severities: A microdialysis study. J. Neurochem. 60:1993;128-136.
119. Root-Bernstein R. S., Westall F. C. Sleep factors: Do muramyl peptides activate the serotonin binding sites? Lancet. i:1983;653.
120. Roszman T. L., Sparks D. L., Slevin J. T., Markesbery W. R., Jackson J. C., Cross R. J. The presence of serotonin receptors on murine lymphocytes and macrophages (abstract). Soc. Neurosci. 10:1984;726.
121. Roszman T. L., Jackson J. C., Cross R. J., Titus M. J., Markesbery W. R., Brooks W. H. Neuroanatomic and neurotransmitter influences on immune function. J. Immunol. 135:1985;769s-772s.
122. Saito A., Lee T. J. F. Serotonin as an alternative transmitter in sympathetic nerves of large cerebral arteries of the rabbit. Circ. Res. 60:1987;220-228.
123. Sarna G. S., Obrenovitch T. P., Matsumoto T., Symon L., Curzon G. Effect of transient cerebral ischemia and cardiac arrest on brain extracellular dopamine and serotonin as determined byin vivo. J. Neurochem. 55:1990;937-940.
124. Schwartz A., Askenase P. W., Gershon R. K. The effect of locally injected vasoactive amines on the elicitation of delayed-type hypersensitivity. J. Immunol. 118:1977;159-165.
125. Shintani F., Kanba S., Nakaki T., Nibuya M., Kinoshita N., Suzuki E., Yagi G., Kato R., Asai M. Interleukin-1beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. J. Neurosci. 13:1993;3574-3581.
126. Silverman D. H. S., Wu H., Karnovsky M. L. Muramyl pepides and serotonin interact at specific binding sites on macrophages and enhance superoxide release. Biochem. Biophys. Res. Comm. 131:1985;1160-1167.
127. Slauson D. O., Walker C., Kristensen F., Wang Y., De Weck A. L. Mechanisms of serotonin-induced lymphocyte proliferation inhibition. Cell. Immunol. 84:1984;240-252.
128. Stanley M. I., Berger R. J., Zuccarello M., Keller J. T. Serotonin (5-HT) fibers of the rat dura mater: 5-HT-positive, but not authentic serotonergic, tryptophan hydroxylase-like fibers. Neurosci. Lett. 162:1993;89-92.
129. Sternberg E. M., Trial J., Parker C. W. Effect of serotonin on murine macrophages: Suppression of Ia expression by serotonin and its reversal by 5-HT2 serotonergic receptor antagonists. J. Immunol. 137:1986;276-282.
130. Sternberg E. M., Wedner H. J., Leung M. K., Parker C. W. Effect of serotonin (5-HT) and other monoamines on murine macrophages: Modulation of Interferon-gamma induced phagocytosis. J. Immunol. 138:1987;4360-4365.
131. Thoa N. B., Eccleston D., Axelrod J. The accumulation of C14-serotonin in the guinea pig vas deferens. J. Pharmacol. Exp. Ther. 169:1969;68-73.
132. Tsai T. H., Chen C. F. In vivo. J. Chromatogr. 730:1996;121-123.
133. Twarog B. M., Page I. H. Serotonin content of some mammalian tissues and urine and a method for its determination. Am. J. Physiol. 175:1953;157-161.
134. Ungerstedt U., Hallstrom A. In vivo. Life Sci. 41:1987;861-864.
135. Verbeuren T. J., Jordaens F. H., Herman A. G. Accumulation and release of (3H)-5-hydroxytryptamine in saphenous veins and cerebral arteries of the dog. J. Pharmacol. Exp. Ther. 226:1983;579-588.
136. Verhofstad A. A. J., Jonsson G. Immunohistochemical and neurochemical evidence for the presence of serotonin in the adrenal medulla of the rat. Neuroscience. 10:1983;1443-1453.
137. Yoshioka M., Kikuchi A., Matsumoto M., Ushiki T., Minami M., Saito H. Evaluation of 5-hydroxytryptamine concentration in portal vein measured by microdialysis. Res. Comm. Chem. Pathol. Pharmacol. 79:1993;370-376.
138. Young M. R. I., Kut J. L., Coogan M. P., Wright M. A., Young M. E., Matthews J. Stimulation of splenic T-lymphocyte function by endgenuous serotonin and by low-dose exogenous serotonin. Immunology. 80:1993;395-400.
139. Young M. R. I., Matthews J. P. Serotonin regulation of T-cell subpopulations and of macrophage accessory function. Immunology. 84:1995;148-152.
140. Waxman F., Taguiam J., Whitacre C. Modification of the clinical and histopathologic expression of experimental allergic encephalomyelitis by the vasoactive amine antagonist cyproheptadine. Cell. Immunol. 85:1984;82-93.
141. Wekerle H., Linington C., Lassmann H., Meyermann R. Cellular immune reactivity within the CNS. Trends Neurosci. 9:1986;271-277.
142. Wester P., Dietrich W. D., Prado R., Watson B. D., Globus M. Y. T. Serotonin release into plasma during common carotid artery thrombosis in rats. Stroke. 23:1992;870-875.
143. Zhu J., Bengtsson B. O., Mix E., Thorell L. H., Olsson T., Link H. Peripheral nerve myelin modulates the effect of antidepressants on major histocompatibility complex expression on macrophages in experimental allergic neuritis. Int. J. Immunopathol. Pharmacol. 8:1995;185-198.